1-3 of 3
Lydia Luy Tan
Close
Sort by
Journal Articles

Cytokine Treatment of CD34 + Cord Blood Cells with G-CSF, GM-CSF, or SCF During 48 Hours of Ex Vivo Culture Alters CD26/DPPIV Peptidase Activity and Subsequent Engraftment Into NSG Immunodeficient Mice.

Laura A Paganessi, MA, Lydia Luy Tan, BS, Sucheta Jagan, MS, Robin Frank, BS, Antonio M. Jimenez, MD, Elizabeth Shima Rich, MD, PhD, Sunita Nathan, MD, John Maciejewski, MD, PhD, Henry C. Fung, FRCP, MD, Kent W. Christopherson, II, PhD
Journal: Blood
Blood (2010) 116 (21): 1460.
https://doi.org/10.1182/blood.V116.21.1460.1460
Published: 2010
Journal Articles

Gain of CD20 Target Cell Surface Receptor Expression During Serum-Free Ex Vivo Culture of CD19 + CD5 + B-Cells In a Sub-Population of Early Stage (Rai 0/1) Chronic Lymphocytic Leukemia Patients

Robin Frank, BS, Hugo Jimenez, Sucheta Jagan, MS, Lydia Luy Tan, BS, Laura A Paganessi, MA, Melissa L Larson, MD, Parameswaran Venugopal, MD, Stephanie A. Gregory, MD, Kent W Christopherson, II, PhD
Journal: Blood
Blood (2010) 116 (21): 2000.
https://doi.org/10.1182/blood.V116.21.2000.2000
Published: 2010
Journal Articles

Use of the CD26 Inhibitor Diprotin A (Ile-Pro-Ile) to Increase Mobilized Peripheral Blood Mononuclear Cell Adhesion and Migration.

Robin Frank, Sucheta Jagan, Lydia Luy Tan, Laura A Paganessi, Kent W. Christopherson, II, PhD
Journal: Blood
Blood (2009) 114 (22): 372.
https://doi.org/10.1182/blood.V114.22.372.372
Published: 2009